U.S. Markets open in 26 hrs, 28 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,318.16 | -14.28 | -0.14% |
| NASDAQ | 2,146.04 | -10.78 | -0.50% |
| S&P 500 | 1,091.38 | -3.52 | -0.32% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 1.33 03:41 PM EST | |
|---|---|---|
| Day High | 1.45 09:31 AM EST |
|
| Range | 0.12 |
| Volume | 250,383 | |
|---|---|---|
| 30-Day Avg Vol | 570,000 |
|
| Difference | -56.07% |
| Market Cap | 50.89 M | |
|---|---|---|
| Mkt Cap Chg | -3.44 M |
| Shares Out | 38.26 M | |
|---|---|---|
| % Shrs Traded | 0.65% | |
| 1yr EPS Est | -0.583 |
| 52-Wk Low | 0.72 | |
|---|---|---|
| 52-Wk High | 6.60 |
|
| Range | 5.88 |
| Prev Close | 1.42 11/19/09 | |
|---|---|---|
| Today's Open | 1.37 | |
| Change | -3.52% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 631,625.00 |
| Revenue (LFY) | 1.59 M | |
|---|---|---|
| Earnings (LFY) | -64.24 M | |
| Earnings (MRQ) | -8.73 M | |
| Next Earn Est | -0.19 | |
| Next Earnings | 11/09/2009 |
|
| EPS (TTM) | -1.35 | |
| 1yr EPS Growth | 56.81% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -2.00 | |
| PEG Ratio | — | |
| Return on Equity | -76.86 | |
| Beta | 2.27 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
ACADIA Pharmaceuticals puts genes and drugs together to fight disease. The development-stage company uses its proprietary R-SAT technology to identify genomic targets for its small-molecule (chemical) ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.19 N/A | — — |
—
—
|
| Last Quarter | -0.243 9/30/09 | -0.23 9/30/09 |
0.013
Beat
|
| 2 Quarters Ago | -0.343 6/30/09 | -0.34 6/30/09 |
0.003
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 2.44 M | 1.59 M |
| Gross Profit | -4.70 M | 547,000.00 |
| Operating Income | -8.77 M | -64.82 M |
| Net Income | -8.73 M | -64.24 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts